Is ABDX or GDR more profitable?

Abingdon Health has a net margin of -33.88% compared to genedrive's net margin of -500.75%. Abingdon Health's return on equity of -55.91% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets Abingdon Health -33.88% -55.91% -17.93% genedrive -500.75% -1,044.57% -74.09%

Is YGEN or GDR more profitable?

Yourgene Health has a net margin of -27.55% compared to genedrive's net margin of -500.75%. Yourgene Health's return on equity of -27.06% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets Yourgene Health -27.55% -27.06% -6.71% genedrive -500.75% -1,044.57% -74.09%

Which has preferable earnings & valuation, GDR or AGL?

genedrive has higher earnings, but lower revenue than ANGLE. genedrive is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio genedrive £929K 20.51 -£21.22M -£0.79 N/A ANGLE £2.62M 2.89 -£21.76M -£4.80 N/A

Is GDR or AGL more profitable?

genedrive has a net margin of -500.75% compared to ANGLE's net margin of -1,444.04%. ANGLE's return on equity of -191.36% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets genedrive -500.75% -1,044.57% -74.09% ANGLE -1,444.04% -191.36% -29.89%

Which has higher earnings and valuation, GDR or GENI?

GENinCode has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio genedrive £929K 20.51 -£21.22M -£0.79 N/A GENinCode £3.08M 1.76 -£6.10M -£2.08 N/A

Is GDR or GENI more profitable?

GENinCode has a net margin of -202.42% compared to genedrive's net margin of -500.75%. GENinCode's return on equity of -481.34% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets genedrive -500.75% -1,044.57% -74.09% GENinCode -202.42% -481.34% -63.99%

Which has preferable earnings & valuation, GDR or VRCI?

Verici Dx has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio genedrive £929K 20.51 -£21.22M -£0.79 N/A Verici Dx £3.66M 1.40 -£6.56M -£0.90 N/A

Is GDR or VRCI more profitable?

Verici Dx has a net margin of -223.60% compared to genedrive's net margin of -500.75%. Verici Dx's return on equity of -127.57% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets genedrive -500.75% -1,044.57% -74.09% Verici Dx -223.60% -127.57% -26.14%

genedrive (GDR) Competitors

GBX 1.12 -0.05 (-4.26%)

As of 11:02 AM Eastern

Compare

GDR vs. ABDX, YGEN, AGL, GENI, and VRCI

Should you buy genedrive stock or one of its competitors? genedrive's main competitors and comparable companies include Abingdon Health (ABDX), Yourgene Health (YGEN), ANGLE (AGL), GENinCode (GENI), and Verici Dx (VRCI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does genedrive compare to Abingdon Health?

Abingdon Health (LON:ABDX) and genedrive (LON:GDR) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

Abingdon Health has higher revenue and earnings than genedrive. Abingdon Health is trading at a lower price-to-earnings ratio than genedrive, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abingdon Health	£9.57M	2.79	-£796.37K	-£0.81	N/A
genedrive	£929K	20.51	-£21.22M	-£0.79	N/A

Abingdon Health has a beta of 0.132, meaning that its share price is 87% less volatile than the broader market. Comparatively, genedrive has a beta of 0.968, meaning that its share price is 3% less volatile than the broader market.

3.7% of Abingdon Health shares are held by institutional investors. Comparatively, 0.1% of genedrive shares are held by institutional investors. 8.0% of Abingdon Health shares are held by insiders. Comparatively, 28.1% of genedrive shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Abingdon Health had 1 more articles in the media than genedrive. MarketBeat recorded 1 mentions for Abingdon Health and 0 mentions for genedrive. Abingdon Health's average media sentiment score of 0.00 equaled genedrive'saverage media sentiment score.

Company	Overall Sentiment
Abingdon Health	Neutral
genedrive	Neutral

Abingdon Health has a net margin of -33.88% compared to genedrive's net margin of -500.75%. Abingdon Health's return on equity of -55.91% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abingdon Health	-33.88%	-55.91%	-17.93%
genedrive	-500.75%	-1,044.57%	-74.09%

Summary

Abingdon Health beats genedrive on 7 of the 12 factors compared between the two stocks.

How does genedrive compare to Yourgene Health?

Yourgene Health (LON:YGEN) and genedrive (LON:GDR) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, risk, institutional ownership and earnings.

Yourgene Health has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Yourgene Health	£29.67M	0.00	-£8.17M	-£0.01	N/A
genedrive	£929K	20.51	-£21.22M	-£0.79	N/A

Yourgene Health has a net margin of -27.55% compared to genedrive's net margin of -500.75%. Yourgene Health's return on equity of -27.06% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Yourgene Health	-27.55%	-27.06%	-6.71%
genedrive	-500.75%	-1,044.57%	-74.09%

23.3% of Yourgene Health shares are held by institutional investors. Comparatively, 0.1% of genedrive shares are held by institutional investors. 64.4% of Yourgene Health shares are held by insiders. Comparatively, 28.1% of genedrive shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Yourgene Health's average media sentiment score of 0.00 equaled genedrive'saverage media sentiment score.

Company	Overall Sentiment
Yourgene Health	Neutral
genedrive	Neutral

Yourgene Health has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market. Comparatively, genedrive has a beta of 0.968, indicating that its stock price is 3% less volatile than the broader market.

Summary

Yourgene Health beats genedrive on 8 of the 10 factors compared between the two stocks.

How does genedrive compare to ANGLE?

genedrive (LON:GDR) and ANGLE (LON:AGL) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

In the previous week, ANGLE had 1 more articles in the media than genedrive. MarketBeat recorded 1 mentions for ANGLE and 0 mentions for genedrive. ANGLE's average media sentiment score of 0.75 beat genedrive's score of 0.00 indicating that ANGLE is being referred to more favorably in the news media.

Company	Overall Sentiment
genedrive	Neutral
ANGLE	Positive

genedrive has higher earnings, but lower revenue than ANGLE. genedrive is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
genedrive	£929K	20.51	-£21.22M	-£0.79	N/A
ANGLE	£2.62M	2.89	-£21.76M	-£4.80	N/A

genedrive has a net margin of -500.75% compared to ANGLE's net margin of -1,444.04%. ANGLE's return on equity of -191.36% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
genedrive	-500.75%	-1,044.57%	-74.09%
ANGLE	-1,444.04%	-191.36%	-29.89%

genedrive has a beta of 0.968, meaning that its share price is 3% less volatile than the broader market. Comparatively, ANGLE has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market.

0.1% of genedrive shares are owned by institutional investors. Comparatively, 17.5% of ANGLE shares are owned by institutional investors. 28.1% of genedrive shares are owned by insiders. Comparatively, 2.7% of ANGLE shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

ANGLE beats genedrive on 7 of the 13 factors compared between the two stocks.

How does genedrive compare to GENinCode?

genedrive (LON:GDR) and GENinCode (LON:GENI) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, profitability and media sentiment.

In the previous week, GENinCode had 5 more articles in the media than genedrive. MarketBeat recorded 5 mentions for GENinCode and 0 mentions for genedrive. genedrive's average media sentiment score of 0.00 beat GENinCode's score of -0.31 indicating that genedrive is being referred to more favorably in the media.

Company	Overall Sentiment
genedrive	Neutral
GENinCode	Neutral

genedrive has a beta of 0.968, meaning that its stock price is 3% less volatile than the broader market. Comparatively, GENinCode has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market.

GENinCode has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
genedrive	£929K	20.51	-£21.22M	-£0.79	N/A
GENinCode	£3.08M	1.76	-£6.10M	-£2.08	N/A

GENinCode has a net margin of -202.42% compared to genedrive's net margin of -500.75%. GENinCode's return on equity of -481.34% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
genedrive	-500.75%	-1,044.57%	-74.09%
GENinCode	-202.42%	-481.34%	-63.99%

0.1% of genedrive shares are owned by institutional investors. Comparatively, 11.4% of GENinCode shares are owned by institutional investors. 28.1% of genedrive shares are owned by insiders. Comparatively, 8.4% of GENinCode shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

GENinCode beats genedrive on 8 of the 13 factors compared between the two stocks.

How does genedrive compare to Verici Dx?

genedrive (LON:GDR) and Verici Dx (LON:VRCI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, dividends and analyst recommendations.

Verici Dx has a net margin of -223.60% compared to genedrive's net margin of -500.75%. Verici Dx's return on equity of -127.57% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
genedrive	-500.75%	-1,044.57%	-74.09%
Verici Dx	-223.60%	-127.57%	-26.14%

genedrive has a beta of 0.968, indicating that its share price is 3% less volatile than the broader market. Comparatively, Verici Dx has a beta of 1.222, indicating that its share price is 22% more volatile than the broader market.

In the previous week, Verici Dx had 1 more articles in the media than genedrive. MarketBeat recorded 1 mentions for Verici Dx and 0 mentions for genedrive. genedrive's average media sentiment score of 0.00 beat Verici Dx's score of -1.58 indicating that genedrive is being referred to more favorably in the media.

Company	Overall Sentiment
genedrive	Neutral
Verici Dx	Very Negative

0.1% of genedrive shares are owned by institutional investors. Comparatively, 15.9% of Verici Dx shares are owned by institutional investors. 28.1% of genedrive shares are owned by insiders. Comparatively, 1.2% of Verici Dx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Verici Dx has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
genedrive	£929K	20.51	-£21.22M	-£0.79	N/A
Verici Dx	£3.66M	1.40	-£6.56M	-£0.90	N/A

Summary

Verici Dx beats genedrive on 9 of the 13 factors compared between the two stocks.

Get genedrive News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GDR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GDR vs. The Competition

Export

Metric	genedrive	Life Sciences Tools & Services Industry	Healthcare Sector	LON Exchange
Market Cap	£18.06M	£10.67B	£7.10B	£2.83B
Dividend Yield	1.57%	1.45%	2.54%	6.26%
P/E Ratio	-1.42	31.75	273.96	366.33
Price / Sales	19.44	423.33	634.66	89,071.63
Price / Cash	2.00	27.32	27.22	27.89
Price / Book	0.40	6.87	11.09	6.96
Net Income	-£21.22M	£57.48B	£3.49B	£5.89B
7 Day Performance	-6.02%	-0.29%	-2.30%	-0.62%
1 Month Performance	-20.77%	7.02%	-7.05%	-1.07%
1 Year Performance	378.72%	29.36%	5.65%	22.84%

genedrive Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GDR genedrive	N/A	GBX 1.13 -4.3%	N/A	+405.1%	£18.06M	£929K	N/A	43	Gap Up
ABDX Abingdon Health	N/A	GBX 10.57 -3.9%	N/A	+75.0%	£27.80M	£9.57M	N/A	84	Gap Down
YGEN Yourgene Health	N/A	N/A	N/A	N/A	£16.43M	£29.67M	N/A	253
AGL ANGLE	N/A	GBX 2.35 -11.3%	N/A	-14.5%	£7.58M	£2.62M	N/A	650	Gap Up
GENI GENinCode	N/A	GBX 0.73 +4.3%	N/A	-82.0%	£5.27M	£3.08M	N/A	2,300	Earnings Report Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:GDR) was last updated on 10/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

genedrive (GDR) Competitors

GDR vs. ABDX, YGEN, AGL, GENI, and VRCI

How does genedrive compare to Abingdon Health?

Summary

How does genedrive compare to Yourgene Health?

Summary

How does genedrive compare to ANGLE?

Summary

How does genedrive compare to GENinCode?

Summary

How does genedrive compare to Verici Dx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GDR vs. The Competition

genedrive Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

genedrive (GDR) Competitors

GDR vs. ABDX, YGEN, AGL, GENI, and VRCI

How does genedrive compare to Abingdon Health?

Which has better valuation and earnings, ABDX or GDR?

Which has more volatility & risk, ABDX or GDR?

Do institutionals and insiders have more ownership in ABDX or GDR?

Does the media refer more to ABDX or GDR?

Is ABDX or GDR more profitable?

Summary

How does genedrive compare to Yourgene Health?

Which has better valuation & earnings, YGEN or GDR?

Is YGEN or GDR more profitable?

Do insiders & institutionals hold more shares of YGEN or GDR?

Does the media prefer YGEN or GDR?

Which has more risk & volatility, YGEN or GDR?

Summary

How does genedrive compare to ANGLE?

Does the media refer more to GDR or AGL?

Which has preferable earnings & valuation, GDR or AGL?

Is GDR or AGL more profitable?

Which has more volatility & risk, GDR or AGL?

Do institutionals and insiders hold more shares of GDR or AGL?

Summary

How does genedrive compare to GENinCode?

Does the media prefer GDR or GENI?

Which has more volatility and risk, GDR or GENI?

Which has higher earnings and valuation, GDR or GENI?

Is GDR or GENI more profitable?

Do institutionals and insiders hold more shares of GDR or GENI?

Summary

How does genedrive compare to Verici Dx?

Is GDR or VRCI more profitable?

Which has more risk and volatility, GDR or VRCI?

Does the media refer more to GDR or VRCI?

Do institutionals & insiders believe in GDR or VRCI?

Which has preferable earnings & valuation, GDR or VRCI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GDR vs. The Competition

genedrive Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools